Ted Baker logo

TED - Ted Baker News Story

307p 2.0  0.7%

Last Trade - 20/02/20

Consumer Cyclicals
Small Cap
Market Cap £135.9m
Enterprise Value £455.7m
Revenue £615.3m
Position in Universe 897th / 1836


Mon 2nd December, 2019 7:00am
RNS Number : 2384V
Ted Baker PLC
02 December 2019

December 2nd 2019

Ted Baker Plc

("Ted Baker" or the "Company")



Ted Baker has identified that the value of inventory held on its balance sheet has been overstated.  Based on preliminary analysis, the Board estimates an impact on value of £20m to £25m. The Board believes that any adjustment to inventory value will have no cash impact and will relate to prior years. 

The Board has appointed Freshfields Bruckhaus Deringer LLP, and will be appointing independent accountants, to undertake a comprehensive review of this issue, and they will report to a sub-committee, chaired by independent director Sharon Baylay.  All costs and fees associated with completing the independent review will be expensed in the period incurred and clearly identified as such.

Ted Baker is committed to ensuring the independent review is completed in an efficient and transparent manner and will update the market as appropriate.   Whilst the review is ongoing, the Company will not comment further.

As scheduled, Ted Baker Plc will be announcing its Trading Update for the 17 week period from 11 August 2019 to 7 December 2019 on Wednesday 11 December 2019.


This announcement contains inside information for the purposes of Article 7 of Regulation (EU) NO 596/2014.



Ted Baker Plc

Lindsay Page, Chief Executive Officer                                                   

Rachel Osborne, Chief Financial Officer


Hudson Sandler LLP (public relations)                                                    Tel: +44 (0) 20 7796 4133

Alex Brennan / Hattie Dreyfus / Nick Moore


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.